LON:VRP Verona Pharma plc (VRP.L) (VRP) Share Forecast, Price & News GBX 55 +3.00 (+5.77%) (As of 10/29/2020) Add Share Share Today's Range 50▼ 5650-Day Range 55▼ 5552-Week Range 28.60▼ 115Volume70,791 shsAverage Volume150,610 shsMarket Capitalization£228.00 millionAssets Under ManagementN/ADividend YieldN/ANet Expense Ratio0.00% ProfileProfileChartHeadlinesOptions ChainProfileChartHeadlinesOptions Chain About Verona Pharma plc (VRP.L) (LON:VRP)Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.Read More VRP Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VRP ETF News HeadlinesSeptember 23, 2023 | americanbankingnews.comVerona Pharma plc (VRP.L) (LON:VRP) Stock Passes Above 200-Day Moving Average of $55.00September 5, 2023 | msn.comVerona Pharma: De-Risked COPD Biotech Play, Approval Likely Coming SoonSeptember 29, 2023 | PressReach (Ad)Uranium Prices Surge as Nuclear Energy Becomes KeyRenewed interest in uranium and rising prices have created a favorable environment for new projects.September 2, 2023 | msn.comCanaccord Genuity Reiterates Verona Pharma Plc - ADR (VRNA) Buy RecommendationSeptember 1, 2023 | benzinga.comExpert Ratings for Verona PharmaAugust 31, 2023 | benzinga.comChristina Ackermann Joins Verona Pharma as Non-Executive DirectorAugust 4, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Verona Pharma (VRNA)July 26, 2023 | benzinga.comVerona Pharma to Present at 43rd Annual Canaccord Growth ConferenceSeptember 29, 2023 | PressReach (Ad)Uranium Prices Surge as Nuclear Energy Becomes KeyRenewed interest in uranium and rising prices have created a favorable environment for new projects.July 20, 2023 | benzinga.comVerona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate UpdateSee More Headlines Receive VRP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verona Pharma plc (VRP.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Verona Pharma plc (VRP.L) (VRP)Full Holdings Details Key ExecutivesDr. Jan-Anders Karlsson (Age 64)CEO & Exec. Director Mr. Piers John Morgan (Age 53)Chief Financial Officer Ms. Claire Louise Poll L.C.S.W. (Age 52)B.A., B Juris, LLB, ASIA, Gen. Counsel Ms. Victoria StewartDirector of CommunicationsDr. Peter Spargo (Age 57)Sr. VP of Chemistry Manufacturing & Controls VRP ETF - Frequently Asked Questions How have VRP shares performed in 2023? Verona Pharma plc (VRP.L)'s stock was trading at GBX 55 at the start of the year. Since then, VRP shares have increased by 0.0% and is now trading at GBX 55. View the best growth stocks for 2023 here. How were Verona Pharma plc (VRP.L)'s earnings last quarter? Verona Pharma plc (VRP.L) (LON:VRP) issued its earnings results on Thursday, February, 27th. The company reported ($30.30) EPS for the quarter, beating the consensus estimate of ($30.80) by $0.50. What other stocks do shareholders of Verona Pharma plc (VRP.L) own? Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Grifols (GRFS) and Innoviva (INVA). What is Verona Pharma plc (VRP.L)'s stock symbol? Verona Pharma plc (VRP.L) trades on the London Stock Exchange (LON) under the ticker symbol "VRP." How do I buy shares of Verona Pharma plc (VRP.L)? Shares of VRP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Verona Pharma plc (VRP.L)'s stock price today? One share of VRP stock can currently be purchased for approximately GBX 55. How much money does Verona Pharma plc (VRP.L) make? Verona Pharma plc (VRP.L) (LON:VRP) has a market capitalization of £228.00 million. How can I contact Verona Pharma plc (VRP.L)? Verona Pharma plc (VRP.L)'s mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The official website for the company is www.veronapharma.com. The company can be reached via phone at +44-20-32834200. This page (LON:VRP) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc (VRP.L) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.